Asslaber, D., Qi, Y., Maeding, N., Steiner, M., Denk, U., Höpner, J. P., . . . Egle, A. (2019). B-cell–specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion. Blood.
Chicago Style CitationAsslaber, Daniela, et al. "B-cell–specific IRF4 Deletion Accelerates Chronic Lymphocytic Leukemia Development By Enhanced Tumor Immune Evasion." Blood 2019.
MLA CitationAsslaber, Daniela, et al. "B-cell–specific IRF4 Deletion Accelerates Chronic Lymphocytic Leukemia Development By Enhanced Tumor Immune Evasion." Blood 2019.
Warning: These citations may not always be 100% accurate.